Zura Bio Limited Class A Ordinary Shares (ZURA)
Healthcare
Biotechnology
5.40 $
-2.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Zura Bio Limited Class A Ordinary Shares (ZURA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 53.6% of the shares are freely tradable; institutional investors hold 78.6%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
78.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
21.5%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
53.6%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
8.3%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
95Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 9.54 | 9,067,001 | +62.9 | 03/31/2026 |
| VR Adviser, LLC | 6.77 | 6,434,990 | +20.4 | 03/31/2026 |
| JPMorgan Chase & Co | 4.69 | 4,458,851 | -0.3 | 03/31/2026 |
| Great Point Partners LLC | 4.44 | 4,215,930 | +10.5 | 03/31/2026 |
| BRAIDWELL LP | 4.20 | 3,988,989 | +25.4 | 03/31/2026 |
| Siren, L.L.C. | 3.93 | 3,734,866 | +187.3 | 03/31/2026 |
| COMMODORE CAPITAL LP | 3.42 | 3,250,000 | +0.0 | 03/31/2026 |
| Pfizer Inc | 2.99 | 2,838,913 | -4.4 | 03/31/2026 |
| Adage Capital Partners Gp LLC | 2.89 | 2,750,000 | +0.0 | 03/31/2026 |
| Affinity Asset Advisors, LLC | 2.70 | 2,564,303 | +41.4 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.